Trials / Terminated
TerminatedNCT01410903
Immunoadsorption in Patients With Severe Systemic Sclerosis
Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- GWT-TUD GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TheraSorb Ig | 1,5 plasma volume per treatment venovenous immunoadsorption frequency: three times weekly in week 1 and 2, two times weekly in week 3-6, two times two-weekly in week 7-12 duration: 12 months |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-07-01
- Completion
- 2012-08-01
- First posted
- 2011-08-05
- Last updated
- 2015-08-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01410903. Inclusion in this directory is not an endorsement.